Skip to content

Depression in Adolescents – The Search for Alternative Approaches to the Prevention of Depression Through the ‘Active form of Meditation’ (AFM) – Pilot Study

Magdalena Maria Cieśla, Piotr Cieśla, Agnieszka Zok, Natalia Woźniak, Paulina Wojtyła-Buciora, Ewa Mojs

Biuletyn Głównej Biblioteki Lekarskiej December 1, 2023 DOI: 10.2478/bgbl-2023-0033 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Pilot study Peer reviewed
Topics Depression Meditation
Key points The abstract states the purpose of the pilot study is to analyze the potential use of an active form of meditation for prevention and alleviation of depressive symptoms, but it does not report any findings or conclusions.

Abstract

Abstract Depression is a reason of the most common causes of premature death. Therefore, it becomes crucial, to find simple preventive measures. Many research show that the combination of pharmacotherapy and mind-body interventions is an effective way. The purpose of the pilot study is to analyze the potential use of an active form of meditation for prevention and alleviation of depressive symptoms.

Comparable studies

Other non-randomized and open-label trials on depression, most cited first.

Study Year Design Participants
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Patients with moderate-to-severe, unipolar, treatment-resistant major depression 2016 Open-label feasibility trial n = 12
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Patients with severe, unipolar, treatment-resistant major depression 2017 Open-label trial n = 20
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression 2018 Clinical trial n = 20
Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder Subjects with DSM-IV-diagnosed treatment-resistant major depressive disorder 2010 Open-label trial n = 33
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression Patients with recurrent depression 2015 Open-label trial n = 17

Citations in the library

Explore topics